相关实验视频

Updated: Jan 11, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K

[宫癌查: hr-HPV测试的实施]

Sarah Ongaro1, Joëlle Desreux2, Pierre-Luc Tremblay-Lemoine2

  • 1Département de Gynécologie-Obstétrique, CHU Liège, Belgique.

Revue medicale de Liege
|November 13, 2025
PubMed
概括

宫癌查正在随着人类乳头瘤病毒 (HPV) 检测而发展,有助于早期检测并降低死亡率. 通过接种疫苗进行初级预防对女孩和男孩都至关重要.

关键词:
宫部查 宫部查准则 准则 准则 准则测试HPV检测 测试HPV检测 测试

更多相关视频

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.9K

相关概念视频

Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
554